Marico Limited has successfully completed the acquisition of a 75% stake in Vietnam-based Skinetiq Joint Stock Company, a move aimed at expanding its presence in the skincare market. The transaction, executed through Marico South East Asia Corporation (MSEA), a wholly owned subsidiary of Marico, was finalised on April 2, 2026.
Skinetiq, which owns the digital-first skincare brand ‘Candid’, also holds exclusive distribution rights for the brand ‘Murad’ in Vietnam. With the completion of this acquisition, Skinetiq has now become a subsidiary of MSEA and, by extension, a subsidiary of Marico Limited.
This strategic acquisition aligns with Marico’s efforts to strengthen its foothold in the Southeast Asian market, particularly in the fast-growing skincare segment. The company had initially announced the proposal to acquire the majority stake in Skinetiq on February 9, 2026.
Further details regarding the acquisition have been made available on Marico’s official website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).